BioGX https://validator.w3.org/feed/docs/rss2.html 450-096-LMP SRM15 – Candida glabrata_ Candida auris_ Candida tropicalis_PI_Rev04_20MAR2026_Rev.04_20MAR2026 Home-BioGX-Live pixl Product Page ENGLISH-VERSION-350-003-A-MAX-Atypical-pneumoniae-PI-Rev.-06-27AUG2021 Atyp-350003AMAXnas_v7 ENGLISH-VERSION-350-002-A-MAX-Plasmodium-PI-Rev.-05-27AUG2021 Plasmodium350002AMAX-UDP-Report-v3 Plasm-350002AMAX_v3 350-002-A-MAX Int. Product Documents BioGX-Inc.-Master-Mix-US-SDS-Version-10-27JAN2026 BioGX-Inc-Reagent-Buffer-US-SDS-Version-04-27JAN2026 BioGX-pixl-real-time-PCR-Platform-Flyer_Ver_1.8 450-043-Series Candida auris PI Rev05_03Nov2025 Candida auris Xfree™ COVID-19 Direct RT-PCR 450-043-Series Candida auris PI Rev05_03Nov2025 450-019-Series ABRM2 – VIM, GES, mcr-1 PI Rev07_08APR2026 450-018-Series ABRM1 – KPC, NDM, OXA-48 Rev06_08APR2026 450-013-Series Streptococcus pyogenes PI Rev05_08APR2026 BioGX BD MAX Product Catalog Measles Virus PCR Assay Atyp-350003AMAXsp_v7 Measles Flyer Rev_03 450-097-LMP SRM16 – Candida krusei_ Candida albicans_ Candida parapsilosis_PI_Rev03_20MAR2026_Rev.03_20MAR2026 Wound Urinary Tract Sexual Health Antimicrobial Resistance 450-113-LMP SPC – RNase P PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-112-LMP ABRS15 – Tetracycline Resistance (tetABMS) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-111-LMP ABRS14 – Quinolone Resistance (qnrB) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-110-LMP ABRS13 – Quinolone Resistance (qnrAS) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-109-LMP ABRS12 – Macrolide Resistance (ermABC) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-108-LMP ABRS11 – Nitroimidazole Resistance (nimBDEJ) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-107-LMP ABRS10 – Sulfonamide Resistance (sul1_sul2) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-106-LMP ABRS9 – Trimethoprim Resistance (dfrA1_dfrA5_dfrA12_dfrA17) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-105-LMP ABRS8 – Carbapenem Resistance (IMP) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-104-LMP ABRS7 – ESBL (TEM) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-103-LMP ABRS6 – ESBL (SHV) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-102-LMP ABRS5 – ESBL (CTX-M) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-101-LMP ABRS4 – Cephalosporin Resistance (CMY_DHA_LAT_MOX_MOR and BIL) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-100-LMP ABRS3 – Cephalosporin Resistance (ACC_ ACT_ FOX_ MIR) PI_Rev04_20MAR2026_Rev.04_20MAR2026 450-099-LMP ABRS2 – Aminoglycoside Resistance (APH) PI_Rev03_20MAR2026_Rev.03_20MAR2026 Atyp-350003AMAX-Sputum-UDP-Report-v7 450-098-LMP ABRS1 – Aminoglycoside Resistance (Aad and AAC) PI_Rev04_20MAR2026_Rev.04_20MAR2026 BioGX Multi-Platform Product Catalog_Rev. 1.8 450-097-LMP SRM16 – Candida krusei_ Candida albicans_ Candida parapsilosis_PI_Rev03_20MAR2026_Rev.03_20MAR2026 BioGX Product Catalog_Rev 1.9 Atyp-350003AMAX-Nasal-Wash-UDP-Report-v7